UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia

Leukemia, 2017-05, Vol.31 (5), p.1196-1205

2017

Volltextzugriff (PDF)

AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells

Leukemia, 2014-12, Vol.28 (12), p.2416-2418

2014

Volltextzugriff (PDF)

BCR ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress

Leukemia, 2008-10, Vol.22 (10), p.1969-1972

2008

Volltextzugriff (PDF)

BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability

Leukemia, 2013-03, Vol.27 (3), p.629-634

2013

Volltextzugriff (PDF)

Fusion tyrosine kinases: a result and cause of genomic instability

Oncogene, 2007-01, Vol.26 (1), p.11-20

2007

Volltextzugriff (PDF)

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway

The EMBO journal, 1997-10, Vol.16 (20), p.6151-6161

1997

Volltextzugriff (PDF)

Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice

Leukemia, 2013-11, Vol.27 (11), p.2253-2254

2013

Volltextzugriff (PDF)

Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma

The Journal of immunology (1950), 2002-01, Vol.168 (1), p.466-474

2002

Volltextzugriff (PDF)

BCR ABL kinase interacts with and phosphorylates the RAD51 paralog, RAD51B

Leukemia, 2009-12, Vol.23 (12), p.2308-2310

2009

Volltextzugriff (PDF)

Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis

Leukemia, 2011-08, Vol.25 (8), p.1259-1267

2011

Volltextzugriff (PDF)

Oncogenic tyrosine kinases and the dna-damage response

Nature reviews. Cancer, 2002-05, Vol.2 (5), p.351-360

Skorski, Tomasz

2002

Volltextzugriff (PDF)

Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases

The Journal of clinical investigation, 1997-07, Vol.100 (1), p.149-157

1997

Volltextzugriff (PDF)

Phosphatidylinositol-3 Kinase Activity Is Regulated by BCR/ABL and Is Required for the Growth of Philadelphia Chromosome-Positive Cells

Blood, 1995-07, Vol.86 (2), p.726-736

1995

Volltextzugriff (PDF)

BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability

Oncogene, 2002-12, Vol.21 (56), p.8591-8604

Skorski, Tomasz

2002

Volltextzugriff (PDF)

De novo Decorin Gene Expression Suppresses the Malignant Phenotype in Human Colon Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 1995-07, Vol.92 (15), p.7016-7020

1995

Volltextzugriff (PDF)

Chronic myeloid leukemia - some topical issues

Leukemia, 2007-07, Vol.21 (7), p.1347-1352

2007

Volltextzugriff (PDF)

Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity

Molecular and Cellular Biology, 1995-11, Vol.15 (11), p.6075-6087

1995

Volltextzugriff (PDF)

Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells

Oncogene, 2000-08, Vol.19 (36), p.4117-4124

2000

Volltextzugriff (PDF)

Not only gene mutation matters: Development of flow cytometry panel to determine BRCA2 deficiency for personalised therapy by PARP inhibitors in pancreatic cancers

Annals of oncology, 2019-11, Vol.30, p.vii18

2019

Volltextzugriff (PDF)

59PNot only gene mutation matters: Development of flow cytometry panel to determine BRCA2 deficiency for personalised therapy by PARP inhibitors in pancreatic cancers

Annals of oncology, 2019-11, Vol.30 (Supplement_7)

2019

Volltextzugriff (PDF)

BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species–dependent DNA double-strand breaks

Blood, 2004-12, Vol.104 (12), p.3746-3753

2004

Volltextzugriff (PDF)

Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571

Oncogene, 2002-08, Vol.21 (38), p.5868-5876

2002

Volltextzugriff (PDF)

Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes

The Journal of experimental medicine, 1995-12, Vol.182 (6), p.1645-1653

1995

Volltextzugriff (PDF)

BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance

Molecular cell, 2001-10, Vol.8 (4), p.795-806

2001

Volltextzugriff (PDF)

Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis

Molecular and cellular biology, 2002-06, Vol.22 (12), p.4189

2002

Volltextzugriff (PDF)

1 – 25 von 569

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(519)
Mit Volltextzugriff
(479)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(546)
Polnisch
(24)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(327)
Life Sciences & Biomedicine
(266)
Humans
(211)
Animals
(135)
Mice
(111)
Oncology
(70)
Biological And Medical Sciences
(68)
Male
(62)
Biochemistry & Molecular Biology
(56)
Hematology
(55)
Dna Damage
(54)
Cell Biology
(51)
Dna Repair
(47)
Medical Sciences
(47)
Leukemia
(45)
Sport Sciences
(44)
Fusion Proteins, Bcr-Abl - Genetics
(42)
Female
(41)
Technology
(39)
Mutation
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia

AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells

BCR ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress

BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability

Fusion tyrosine kinases: a result and cause of genomic instability

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway

Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice

Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma

BCR ABL kinase interacts with and phosphorylates the RAD51 paralog, RAD51B

Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis

Oncogenic tyrosine kinases and the dna-damage response

Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases

Phosphatidylinositol-3 Kinase Activity Is Regulated by BCR/ABL and Is Required for the Growth of Philadelphia Chromosome-Positive Cells

BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability

De novo Decorin Gene Expression Suppresses the Malignant Phenotype in Human Colon Cancer Cells

Chronic myeloid leukemia - some topical issues

Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity

Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells

Not only gene mutation matters: Development of flow cytometry panel to determine BRCA2 deficiency for personalised therapy by PARP inhibitors in pancreatic cancers

59PNot only gene mutation matters: Development of flow cytometry panel to determine BRCA2 deficiency for personalised therapy by PARP inhibitors in pancreatic cancers

BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species–dependent DNA double-strand breaks

Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571

Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes

BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance

Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis

Suchergebnisse filtern